DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar paden55 (65.21) Submitted: 12/1/2006 12:57:41 AM : Outperform Start Price: $4.66 DRRX Score: -79.89

Back to it's 52 week high of 6.4 on the news. Fell short today, but it will still have legs.

Featured Broker Partners


Advertisement